Company
SURGE Therapeutics
SURGE Therapeutics has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BCS + SRG-514 | Phase 3 | TNBC - Triple-Negative Breast Cancer |
Latest
No recent events.
Follow SURGE Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.